Joachim Pfannschmidt

Nov 28, 2023 | frontiersin.org | Ulrich Ronellenfitsch |David Morris |Marcello Migliore |Joachim Pfannschmidt

1 IntroductionFor many tumours, development of synchronous or metachronous metastases correlates with poor survival (1). This is particularly true in the case of secondary pleural metastases, where local therapy options are significantly limited and only palliative treatment concepts in the sense of systemic chemotherapy or best supportive care can be offered.